BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16165238)

  • 1. The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus.
    Valentini V; Glimelius B; Minsky BD; Van Cutsem E; Bartelink H; Beets-Tan RG; Gerard JP; Kosmidis P; Pahlman L; Picciocchi A; Quirke P; Tepper J; Tonato M; Van de Velde CJ; Cellini N; Latini P
    Radiother Oncol; 2005 Sep; 76(3):241-50. PubMed ID: 16165238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2).
    Valentini V; Aristei C; Glimelius B; Minsky BD; Beets-Tan R; Borras JM; Haustermans K; Maingon P; Overgaard J; Pahlman L; Quirke P; Schmoll HJ; Sebag-Montefiore D; Taylor I; Van Cutsem E; Van de Velde C; Cellini N; Latini P;
    Radiother Oncol; 2009 Aug; 92(2):148-63. PubMed ID: 19595467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?
    Chen CC; Lee RC; Lin JK; Wang LW; Yang SH
    Dis Colon Rectum; 2005 Apr; 48(4):722-8. PubMed ID: 15747073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging.
    Koh DM; Chau I; Tait D; Wotherspoon A; Cunningham D; Brown G
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):456-61. PubMed ID: 18164860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
    Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S
    Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rational principles of neo-adjuvant therapy for rectal cancer.
    Tonelli F; Asteria CR; Marcucci T
    Acta Biomed; 2003; 74 Suppl 2():96-102. PubMed ID: 15055045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Magnetic Resonance Imaging in the preoperative staging of rectum cancer].
    Mortensen LA; Leffers AM; Holck S; Bülow S; Achiam M
    Ugeskr Laeger; 2009 Aug; 171(35):2476-81. PubMed ID: 19732535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
    Guillem JG; Díaz-González JA; Minsky BD; Valentini V; Jeong SY; Rodriguez-Bigas MA; Coco C; Leon R; Hernandez-Lizoain JL; Aristu JJ; Riedel ER; Nitti D; Wong WD; Pucciarelli S
    J Clin Oncol; 2008 Jan; 26(3):368-73. PubMed ID: 18202411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence.
    Daniels IR; Fisher SE; Heald RJ; Moran BJ
    Colorectal Dis; 2007 May; 9(4):290-301. PubMed ID: 17432979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
    Smalley SR; Benedetti JK; Williamson SK; Robertson JM; Estes NC; Maher T; Fisher B; Rich TA; Martenson JA; Kugler JW; Benson AB; Haller DG; Mayer RJ; Atkins JN; Cripps C; Pedersen J; Periman PO; Tanaka MS; Leichman CG; Macdonald JS
    J Clin Oncol; 2006 Aug; 24(22):3542-7. PubMed ID: 16877719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiotherapy of rectal cancer].
    Balteskard L; Vonen B; Frykholm G; Dahl O; Tveit KM
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3090-3. PubMed ID: 18049501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent rectal cancer within the pelvis. A multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy.
    Höcht S; Hammad R; Thiel HJ; Wiegel T; Siegmann A; Willner J; Wust P; Herrmann T; Eble M; Flentje M; Carstens D; Bottke D; Neumann P; Hinkelbein W
    Strahlenther Onkol; 2004 Jan; 180(1):15-20. PubMed ID: 14704840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer.
    Glynne-Jones R; Mathur P; Elton C; Train ML
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1049-70. PubMed ID: 18070703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging for preoperative staging of rectal cancer in clinical practice: high accuracy in predicting circumferential margin with clinical benefit.
    Videhult P; Smedh K; Lundin P; Kraaz W
    Colorectal Dis; 2007 Jun; 9(5):412-9. PubMed ID: 17504337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer.
    Maretto I; Pomerri F; Pucciarelli S; Mescoli C; Belluco E; Burzi S; Rugge M; Muzzio PC; Nitti D
    Ann Surg Oncol; 2007 Feb; 14(2):455-61. PubMed ID: 17139456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current practice in preoperative therapy and surgical management of locally advanced rectal cancer: a bi-national survey.
    Ooi K; Frizelle F; Ong E; Faragher I
    Colorectal Dis; 2012 Jul; 14(7):814-20. PubMed ID: 21899709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.
    Eriksen MT; Wibe A; Haffner J; Wiig JN;
    Dis Colon Rectum; 2007 Feb; 50(2):156-67. PubMed ID: 17180256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer.
    Lutz MP; Zalcberg JR; Glynne-Jones R; Ruers T; Ducreux M; Arnold D; Aust D; Brown G; Bujko K; Cunningham C; Evrard S; Folprecht G; Gerard JP; Habr-Gama A; Haustermans K; Holm T; Kuhlmann KF; Lordick F; Mentha G; Moehler M; Nagtegaal ID; Pigazzi A; Pucciarelli S; Roth A; Rutten H; Schmoll HJ; Sorbye H; Van Cutsem E; Weitz J; Otto F
    Eur J Cancer; 2016 Aug; 63():11-24. PubMed ID: 27254838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.